Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration.
García-Layana A, Recalde S, Hernandez M, Abraldes MJ, Nascimento J, Hernández-Galilea E, Olmedilla-Alonso B, Escobar-Barranco JJ, Zapata MA, Silva R, Caballero Arredondo M, Lopez-Sabater MC, Mendez-Martínez S, Pardiñas-Barón N, Calvo P, Fernández-Robredo P. García-Layana A, et al. Among authors: calvo p. Nutrients. 2021 Apr 10;13(4):1253. doi: 10.3390/nu13041253. Nutrients. 2021. PMID: 33920232 Free PMC article. Clinical Trial.
OCULAR ADVERSE EVENTS ASSOCIATED WITH MEK INHIBITORS.
Méndez-Martínez S, Calvo P, Ruiz-Moreno O, Pardiñas Barón N, Leciñena Bueno J, Gil Ruiz MDR, Pablo L. Méndez-Martínez S, et al. Among authors: calvo p. Retina. 2019 Aug;39(8):1435-1450. doi: 10.1097/IAE.0000000000002451. Retina. 2019. PMID: 30681641 Review.
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes.
Zarranz-Ventura J, Parrado-Carrillo A, Nguyen V, Sararols L, Garay-Aramburu G, Puzo M, Arruabarrena C, Figueras-Roca M, Gillies MC, Casaroli-Marano RP; from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Zarranz-Ventura J, et al. Clin Exp Ophthalmol. 2022 Apr;50(3):312-324. doi: 10.1111/ceo.14054. Epub 2022 Feb 20. Clin Exp Ophthalmol. 2022. PMID: 35106882 Free article.
Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data.
Agostini H, Mulyukov Z, Tsilimbaris M, Calvo P, Bucher F, Gaucher D, Pigeolet E, Colafrancesco V, Clemens A. Agostini H, et al. Among authors: calvo p. Curr Eye Res. 2020 Oct;45(10):1298-1301. doi: 10.1080/02713683.2020.1731832. Epub 2020 Feb 26. Curr Eye Res. 2020. PMID: 32065533 Clinical Trial.
378 results